Search
for
Sort by
Research 571–600 of 1000+
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- Minoxidil Acts as an Antiandrogen: A Study of 5α-reductase Type 2 Gene Expression in a Human Keratinocyte Cell Line.
- Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men
- Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Post-finasteride syndrome: An emerging clinical problem
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- A new label-free screen for steroid 5α-reductase inhibitors using LC-MS
- Androgenetic alopecia; drug safety and therapeutic strategies
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Inhibition of 5α-reductase in the rat prostate by Cimicifuga racemosa
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Anti-aging effects of black raspberry extract on cataract, alopecia, skin whitening, and weight loss
- Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
- The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of 5-alpha-dihydrotestosterone in human serum and plasma
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- ANDROGENIC ALOPECIA: PATHOGENETIC MECHANISMS AND THERAPEUTIC APPROACHES